![](https://static.zsdocx.com/FlexPaper/FileRoot/2019-10/30/17/9591807f-6514-4165-8c78-d41f0f2afb22/9591807f-6514-4165-8c78-d41f0f2afb22pic.jpg)
![usp-1663-extractable_第1頁(yè)](https://static.zsdocx.com/FlexPaper/FileRoot/2019-10/30/17/9591807f-6514-4165-8c78-d41f0f2afb22/9591807f-6514-4165-8c78-d41f0f2afb221.gif)
版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、BRIEFING1663AssessmentofExtractablesAssociatedwithPharmaceuticalPackagingDeliverySystems.Inthe2010–2015cyclethePackagingStageDistributionExpertCommitteedeterminedtheneedtoupdategeneralchaptersthatfocusonthequalityofthepa
2、ckagingsystemsusedtostedrugproducts.TheExpertCommitteesinitialfocuswasonthefinalpackagingsystemshoweverithasbeenextendedtoincludepackagingsystemscomponentstheirmaterialsofconstruction.Thesuitabilityofapharmaceuticalpacka
3、gingsystemfadrugproductcanbeassessedbyextractablesleachablestesting.Outoftheseacterizationstudiesspecificcontrolsfapackagingsystemitscomponentsitsmaterialsofconstructioncanbeestablished.Thesuiteofgeneralchaptersfpackagin
4、gsystemsbeginswithPlasticMaterialsofConstruction661.1whichisusedtoacterizethematerialsofconstructionPlasticPackagingSystemsfPharmaceuticalUse661.2whichisusedtoacterizethefinalpackagingsystemcomponent.Otherchaptersthatwil
5、lbeproposedinthefuturewilladdresstheacterizationofplasticmaterialsusedinthemanufacturingprocessmedicaldevicesPlasticSystemsUsedfManufacturingPharmaceuticalProducts661.3PlasticMedicalDevicesUsedtoDeliverAdministerPharmace
6、uticalProducts661.4.AspartofthiscontinuationthePackagingStageDistributionExpertCommitteeisproposingAssessmentofExtractablesAssociatedwithPharmaceuticalPackagingDeliverySystems1663whichpresentsaframewkfthedesignjustificat
7、ionexecutionofanextractablesassessmentfpharmaceuticalpackagingdeliverysystems.AwkshopwillbeheldonDecember9102013atUSPinRockvilleMaryltodiscusscommentsonthesuiteofpackaginggeneralchapterspotentialfuturerevisions.(GCPS:D.H
8、unt.)CrespondenceNumber—C126512Addthefollowing:?1663ASSESSMENTOFEXTRACTABLESASSOCIATEDWITHPHARMACEUTICALPACKAGINGDELIVERYSYSTEMSPURPOSEderivedfromextractableshavethepotentialtoleachintoadrugproductundernmalconditionsofst
9、ageuse.Leachablesareganicinganicchemicalentitiesthatmigratefromapackagingdeliverysystempackagingcomponentpackagingmaterialofconstructionintoanassociateddrugproductundernmalconditionsofstageuseduringaccelerateddrugproduct
10、stabilitystudies.Leachablesaretypicallyasubsetofextractablesarederivedfromextractables.Notethatchemicalentitiescanalsoleachfrompackagingdeliverysystemstopatientsviadirectcontact.ExtractionStudiesaretheoveralllabatyproces
11、sesrequiredindertocreateextractablesprofile(s)ofparticularpharmaceuticalpackagingdeliverysystemspackagingcomponentsmaterialsofconstruction.ExtractionstudiesarealsoreferredtoasControlledExtractionStudies.acterizationisthe
12、discoveryidentificationquantitationofeachindividualganicinganicchemicalentitypresentinanextractaboveaspecifiedlevelthreshold.Suchthresholdscanbebasedonpatientsafetyconsiderationsmaterialsconsiderationsthecapabilitiesofan
13、alyticaltechnologyetc.Scoutingistheprocessofacquiringgeneralchemicalinfmationthatprovidesinsightintothenaturemagnitudeofextractables.Discoveryistheprocessofsearchingfultimatelyfindingindividualganicinganicchemicalentitie
14、spresentinanextract.Identificationistheprocessofassigningamolecularstructuretoanganicextractableassigningconstituentelementsinthecaseofaninganicextractable.Quantitationistheprocessofmeasuringthelevelconcentrationofanindi
15、vidualganicinganicchemicalentitycontainedinanextract.ExtractablesProfilesarequalitativequantitativeanalyticalrepresentationsoftheextractablescontentofaparticularextractingmediumsetoflabatyextractionconditions.LeachablesE
16、xtractablesCrelationsareestablishedwhenobserveddrugproductleachablesarelinkedbothqualitativelyquantitativelytoextractablesfromassociatedpackagingdeliverysystemspackagingcomponentsmaterialsofconstruction.SafetyConcernThre
17、shold(SCT)isthethresholdbelowwhichaleachablehasadosesolowthatitpresentsnegligiblesafetyconcernsfromcarcinogenicnoncarcinogenictoxiceffects.Asnotedadditionalterminologyassociateddefinitionsareavailable(12659).SCOPEThescie
18、ntificprinciplesbestpracticesdescribedinthisgeneralchapterareintendedtoapplytoanyextractablesassessmentextractionstudyofpharmaceuticalpackagingdeliverysystemspackagingcomponentsmaterialsofconstructiontheresultsofwhichare
19、intendedfestablishingextractablesprofiles.Extractablesprofilescanbeusedinavarietyofpharmaceuticaldevelopmentmanufacturingapplicationsincludingtheacterizationionqualificationofmaterialsofconstructionpackagingcomponentspac
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- usp理論意義
- usp法定方法驗(yàn)證
- usp621譯文
- usp氯化鈉譯文
- 幻燈片1-usp
- 牙膏usp廣告案例分析
- (教學(xué)反思參考2)雪地里的小畫(huà)家-(1663)
- usp-51抗菌效力測(cè)試
- usp36 921水分測(cè)定法
- gjb1663a-93艦艇用10crni3mov鋼板規(guī)范
- USP感知對(duì)顧客購(gòu)買(mǎi)意向影響研究.pdf
- usp-1664-leachable-包材析出物研究方法
- 1663.bim技術(shù)在業(yè)主方項(xiàng)目管理中的應(yīng)用效果研究
- 基于usp理論的微信讀書(shū)平臺(tái)研究
- 24633.泛素特異性蛋白酶usp2和usp8催化機(jī)制和底物特異性研究
- 基于USP理論的微信讀書(shū)平臺(tái)研究.pdf
- 《usp32凡例和要求》中的關(guān)注點(diǎn)
- 1663.一維強(qiáng)相互作用冷原子氣體中有效自旋鏈模型研究
- 1663.atms與cris衛(wèi)星輻射資料同化影響青藏高原天氣要素預(yù)報(bào)效果的研究
- USP2抑制劑篩選體系的建立及應(yīng)用.pdf
評(píng)論
0/150
提交評(píng)論